Australia
· Delayed Price · Currency is AUD Rhythm Biosciences Statistics
Total Valuation
ASX:RHY has a market cap or net worth of AUD 17.87 million. The enterprise value is 13.57 million.
| Market Cap | 17.87M |
| Enterprise Value | 13.57M |
Important Dates
The last earnings date was Wednesday, May 21, 2025.
| Earnings Date | May 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:RHY has 283.60 million shares outstanding. The number of shares has increased by 12.11% in one year.
| Current Share Class | 283.60M |
| Shares Outstanding | 283.60M |
| Shares Change (YoY) | +12.11% |
| Shares Change (QoQ) | +8.81% |
| Owned by Insiders (%) | 27.73% |
| Owned by Institutions (%) | 6.83% |
| Float | 183.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.64 |
| PB Ratio | 3.66 |
| P/TBV Ratio | 4.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.24 |
| EV / Sales | 4.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.40 |
Financial Position
The company has a current ratio of 4.87, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.87 |
| Quick Ratio | 4.58 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.07 |
| Interest Coverage | -35.62 |
Financial Efficiency
Return on equity (ROE) is -71.10% and return on invested capital (ROIC) is -41.98%.
| Return on Equity (ROE) | -71.10% |
| Return on Assets (ROA) | -33.68% |
| Return on Invested Capital (ROIC) | -41.98% |
| Return on Capital Employed (ROCE) | -42.95% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.80 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.00% in the last 52 weeks. The beta is 2.04, so ASX:RHY's price volatility has been higher than the market average.
| Beta (5Y) | 2.04 |
| 52-Week Price Change | -10.00% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.08 |
| Relative Strength Index (RSI) | 44.68 |
| Average Volume (20 Days) | 225,531 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:RHY had revenue of AUD 3.17 million and -2.18 million in losses. Loss per share was -0.01.
| Revenue | 3.17M |
| Gross Profit | 4.02M |
| Operating Income | -2.12M |
| Pretax Income | -2.18M |
| Net Income | -2.18M |
| EBITDA | -2.02M |
| EBIT | -2.12M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 4.45 million in cash and 158,659 in debt, giving a net cash position of 4.30 million or 0.02 per share.
| Cash & Cash Equivalents | 4.45M |
| Total Debt | 158,659 |
| Net Cash | 4.30M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 4.88M |
| Book Value Per Share | 0.02 |
| Working Capital | 3.84M |
Cash Flow
In the last 12 months, operating cash flow was -2.12 million and capital expenditures -1,595, giving a free cash flow of -2.12 million.
| Operating Cash Flow | -2.12M |
| Capital Expenditures | -1,595 |
| Free Cash Flow | -2.12M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 126.84%, with operating and profit margins of -67.03% and -68.73%.
| Gross Margin | 126.84% |
| Operating Margin | -67.03% |
| Pretax Margin | -68.73% |
| Profit Margin | -68.73% |
| EBITDA Margin | -63.88% |
| EBIT Margin | -67.03% |
| FCF Margin | n/a |
Dividends & Yields
ASX:RHY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.11% |
| Shareholder Yield | n/a |
| Earnings Yield | -12.18% |
| FCF Yield | -11.86% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:RHY has an Altman Z-Score of 3.2.
| Altman Z-Score | 3.2 |
| Piotroski F-Score | n/a |